TOKYO (Reuters) - U.S. private equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Bain Capital is considering withdrawing its tender offer for Japanese IT firm Fuji Soft after rival U.S. private equity giant ...

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...

Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

Bain Capital kicked off the bidding war for MLC-owner Insignia Financial and has certainly pulled out all the stops to ...

TOKYO (Reuters) - U.S. private equity fund KKR will raise its tender offer price for Fuji Soft shares to 9,850 yen per share ...

The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...

According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.